Bellon Steven F. 4
4 · Foghorn Therapeutics Inc. · Filed Sep 11, 2024
Insider Transaction Report
Form 4
Bellon Steven F.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-09-09$9.50/sh−20,000$190,000→ 101,957 total
Footnotes (1)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024.